Literature DB >> 2506610

Effects of dopamine receptor antagonists on sucrose consumption and preference.

R Muscat1, P Willner.   

Abstract

Effects of the dopamine D2 receptor antagonist sulpiride and the D1 antagonist SCH-23390 were examined, in rats, in two-bottle preference tests (sucrose versus water) and in single-bottle tests, at different sucrose concentrations. Both drugs decreased sucrose intake in single bottle tests, at low sucrose concentrations, but had no effect at high concentrations; reducing drive level had exactly the opposite pattern of effects. In two-bottle tests, both drugs reduced preference for the weakest sucrose concentration (0.7%) but increased preference for the strongest concentration (34%). The effects of antagonizing either subtype of DA receptor appear to be similar to those of reducing the concentration of sucrose.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506610     DOI: 10.1007/bf00634461

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

3.  Effects of pimozide on sucrose consumption and preference.

Authors:  A Towell; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride on saline acceptance-rejection in water-deprived rats.

Authors:  D B Gilbert; S J Cooper
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

5.  Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

Authors:  S Nakajima; G M McKenzie
Journal:  Pharmacol Biochem Behav       Date:  1986-04       Impact factor: 3.533

6.  Some effects of pimozide on nondeprived rats licking sucrose solutions in an anhedonia paradigm.

Authors:  S E Gramling; S C Fowler; K R Collins
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

7.  Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.

Authors:  R J Beninger; M Cheng; B L Hahn; D C Hoffman; E J Mazurski; M A Morency; P Ramm; R J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Sham feeding as a procedure for assessing the influence of diet palatability on food intake.

Authors:  H P Weingarten; S D Watson
Journal:  Physiol Behav       Date:  1982-03

9.  Hedonic reactivity to sucrose in rats: modification by pimozide.

Authors:  C S Bailey; S Hsiao; J E King
Journal:  Physiol Behav       Date:  1986-10

10.  Production of climbing behaviour in mice requires both D1 and D2 receptor activation.

Authors:  N A Moore; M S Axton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  29 in total

Review 1.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.

Authors:  K J Wong; F H W Wojnicki; R L W Corwin
Journal:  Pharmacol Biochem Behav       Date:  2009-02-13       Impact factor: 3.533

3.  Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.

Authors:  Marta Pardo; Laura López-Cruz; Noemí San Miguel; John D Salamone; Mercè Correa
Journal:  Psychopharmacology (Berl)       Date:  2015-02-03       Impact factor: 4.530

4.  Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats.

Authors:  Julie A D Dela Cruz; Tricia Coke; Richard J Bodnar
Journal:  J Vis Exp       Date:  2016-08-24       Impact factor: 1.355

5.  Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement.

Authors:  Samantha R Spierling; Maegan Mattock; Eric P Zorrilla
Journal:  Physiol Behav       Date:  2017-04-19

6.  Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Authors:  M S Cousins; W Wei; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Reward-dependent suppression or facilitation of consummatory behaviour by raclopride.

Authors:  G Phillips; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Role of amygdala dopamine D1 and D2 receptors in the acquisition and expression of fructose-conditioned flavor preferences in rats.

Authors:  Sonia Bernal; Patricia Miner; Yana Abayev; Ester Kandova; Meri Gerges; Khalid Touzani; Anthony Sclafani; Richard J Bodnar
Journal:  Behav Brain Res       Date:  2009-06-30       Impact factor: 3.332

10.  Dopamine D1 and opioid receptor antagonists differentially reduce the acquisition and expression of fructose-conditioned flavor preferences in BALB/c and SWR mice.

Authors:  Tamar T Kraft; Yakov Yakubov; Donald Huang; Gregory Fitzgerald; Elona Natanova; Anthony Sclafani; Richard J Bodnar
Journal:  Physiol Behav       Date:  2015-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.